Comparison
2 3 Layered Lissencephaly C5139357 vs 15q Overgrowth Syndrome
Clinical comparison between 2 3 Layered Lissencephaly and 15q Overgrowth Syndrome for differential diagnosis and treatment planning.
6 comparison axes
Onset
2 3 Layered Lissencephaly C5139357
0-1
15q Overgrowth Syndrome
0-0
Onset patterns differ
Severity
2 3 Layered Lissencephaly C5139357
severe
15q Overgrowth Syndrome
moderate
Different severity levels
Chronic
2 3 Layered Lissencephaly C5139357
Chronic
15q Overgrowth Syndrome
Chronic
Differing course
Communicable
2 3 Layered Lissencephaly C5139357
No
15q Overgrowth Syndrome
No
Different transmission
Body System
2 3 Layered Lissencephaly C5139357
neurologic
15q Overgrowth Syndrome
congenital
Same/different system
Category
2 3 Layered Lissencephaly C5139357
neurologic
15q Overgrowth Syndrome
genetic
Different category
Bottom line
2-3-layered-lissencephaly-C5139357 and 15q-overgrowth-syndrome-C4749920 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2 3 Layered Lissencephaly C5139357 | 15q Overgrowth Syndrome | Discriminating power |
|---|---|---|---|
| Cortical structure | Abnormally layered cerebral cortex, described as 2–3 layers. | No cortical-layer pattern is established in the supplied data. | High |
| Neurologic course | Source describes severe developmental delay, seizures, and motor problems. | Severity axis is moderate; specific neurologic symptoms are not supplied. | Moderate |
| Growth pattern | Not described as an overgrowth disorder. | The name suggests overgrowth, but features and measurements are not established here. | Moderate |
When to favor each condition
Choose 2 3 Layered Lissencephaly C5139357 when
MRI suggests simplified cortex with reduced layers
This matches the named brain malformation better than the overgrowth label.
High
Infant has severe seizures and motor delay
These features are explicitly described for the left condition.
Moderate
Primary problem is neurologic rather than overgrowth
Supplied category is neurologic, without evidence of an overgrowth syndrome.
Moderate
Choose 15q Overgrowth Syndrome when
Confirmed 15q copy-number change with clinical overgrowth
The genetic and congenital axes fit better, but confirmation is required.
Moderate
No imaging evidence of lissencephaly
The right condition is not established here as a cortical-layer disorder.
Moderate
Course appears moderate rather than severe cortical disease
Only the supplied severity axis supports this distinction.
Low
How key tests differ
| Test | 2 3 Layered Lissencephaly C5139357 | 15q Overgrowth Syndrome | Interpretation |
|---|---|---|---|
| Brain MRI | May show lissencephaly and reduced cortical layers. | Expected imaging appearance is not established. | An abnormal scan is a finding and requires specialist correlation. |
| Chromosomal or genomic testing | A genetic cause may exist but is not specified here. | Testing relevant to 15q is suggested by the name. | A genetic result alone does not establish the full diagnosis. |
| Developmental and neurologic assessment | Severe delay, seizures, and motor impairment are described. | Specific deficits are not supplied; severity axis is moderate. | Findings must be interpreted individually by a clinician. |
Prognosis comparison
2 3 Layered Lissencephaly C5139357
- Outcome
- Source supports a severe chronic neurodevelopmental condition; exact outcomes are not quantified.
- Factors
- Seizure burden, motor impairment, and developmental support.
15q Overgrowth Syndrome
- Outcome
- Outcome is not established; the axis only suggests moderate chronic severity.
- Factors
- Genetic confirmation and individual congenital features, which are unspecified.
Time frame: From early life onward; precise timelines are unavailable.
Severity, seizures, growth, comorbidities, and support access; no mortality data are supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Seizures | Described as an important feature. Seizure risk is not established in the source. Do not assume equal seizure complications. |
| Motor impairment | Motor problems are reported. Motor outcome is not specified. Support needs should be individualized. |
| Overgrowth-related complications | Not described as overgrowth. Implied only by the condition name. Prevalence, exact complications, and mortality are not established. |
Patient education highlights
- HighFinding versus diagnosis
MRI or genetic results need specialist review and do not prove every associated feature.
- HighSupportive care
The left source emphasizes seizure management and developmental support; no treatment doses are provided.
- MediumLimited evidence
Data for 15q overgrowth syndrome are sparse here, so prognosis should not be inferred without clinical review.